Literature DB >> 8092891

Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.

K Niwa1, Y Yokoyama, T Tanaka, T Murase, S Morishita, M Itoh, N Itoh, K Shimokawa, T Tamaya.   

Abstract

A 32-year infertile Japanese woman suffered from endometrial cancer, which was treated with repeated endometrial curettage and medroxyprogesterone acetate for 6 months. The patient then became pregnant and was delivered of a live-born male infant at 37 weeks gestation by cesarean section for placenta previa. At cesarean section there were no abnormal findings in the uterine cavity or other pelvic organs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092891     DOI: 10.1007/bf02391803

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Treatment of choice in cancer of the uterine corpus.

Authors:  J B GRAHAM
Journal:  N Engl J Med       Date:  1956-06-14       Impact factor: 91.245

2.  Adenocarcinoma of the endometrium in women 40 years of age or younger.

Authors:  D G Gallup; R J Stock
Journal:  Obstet Gynecol       Date:  1984-09       Impact factor: 7.661

3.  Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?

Authors:  J V Bokhman; O F Chepick; A T Volkova; A S Vishnevsky
Journal:  Gynecol Oncol       Date:  1985-02       Impact factor: 5.482

4.  Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma.

Authors:  R J Kurman; H J Norris
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

  4 in total
  2 in total

Review 1.  Conservative management of patients with early endometrial carcinoma: a systematic review.

Authors:  Luis Chiva de Agustín; Fernando Lapuente Sastre; Virginia Corraliza Galán; Luis Granados Galainena; Antonio González Martín; Lucía González Cortijo; Natalia Carballo González
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

2.  Inhibitory effects of medroxyprogesterone acetate on mouse endometrial carcinogenesis.

Authors:  K Niwa; S Morishita; T Murase; N Itoh; T Tanaka; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1995-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.